Evidenzbasierte Psychotherapie bei Patienten mit Substanzabhängigkeit und psychischer Komorbidität

• Literatur

• 1 Kessler RC, Berglund P, Demler O. et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiat 2006; 62: 593-602
• 2 Kelly TM, Daley DC, Douaihy AB. Treatment of Substance Abusing Patients with Comorbid Psychiatric Disorders. Addict Behav 2012; 37: 11-34
• 3 Schnell T, Gouzoulls-Mayfrank E. Psychotherapie bei Patienten mit Psychose und Sucht – Behandlungsoptionen und ihre Grenzen. Sucht 2011; 57: 383-392
• 4 Horsfall J, Cleary M, Hunt GE. et al. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence. Harv Rev Psychiat 2009; 17: 24-34
• 5 Soyka M, Lieb M. Depression und Alkoholabhängigkeit – Neue Befunde zu Komorbidität, Neurobiologie und Genetik. J Neurol Neurochir Psychiat 2004; 5: 37-46
• 6 Schneider U, Altmann A, Baumann M. et al. Comorbid anxiety and affective disorder in alcohol-dependent patients seeking treatment: the first multicentre study in Germany. Alcohol Alcohol 2001; 36: 219-223
• 7 Gilman SE, Abraham HD. A longitudinal study of the order of onset of alcohol dependence and major depression. Drug Alcohol Depend 2001; 63: 277-286
• 8 Baker AL, Kavanagh DJ, Kay-Lambkin FJ. et al. Randomized controlled trial of cognitive-behavioural therapy for coexisting depression and alcohol problems: short-term outcome. Addiction 2010; 105: 87-99
• 9 Löber S, Dinter C, Mann K. Psychotherapie von Patienten mit Depression und Abhängigkeitserkrankung. Sucht 2011; 57: 373-381
• 10 Pasche S. Exploring the comorbidity of anxiety and substance use disorders. Curr Psychiat Rep 2012; 14: 176-181
• 11 Boschloo L, Vogelzangs L, Smit JH. et al. Comorbidity and risk indicators for alcohol use disorders among persons with anxiety and/or depressive disorders: Findings from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disorders 2011; 131: 233-242
• 12 Gentil AF, de Mathis MA, Torresan RC. et al. Alcohol use disorders in patients with obsessive-compulsive disorder: the importance of appropriate dual-diagnosis. Drug Alcohol Depend 2009; 100: 173-177
• 13 Randall CL, Thomas S, Thevos AK. Concurrent alcoholism and social anxiety disorder: a first step toward developing effective treatments. Alcohol Clin Exp Res 2001; 25: 210-220
• 14 Jacobsen LK, Southwick SM, Kosten TR. Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. Am J Psychiat 2001; 158: 1184-1190
• 15 Najavits LM. Posttraumatische Belastungsstörung und Substanzmissbrauch. Göttingen: Hogrefe; 2009
• 16 Mills K. Treatment of comorbid substance dependence and posttraumatic stress disorder. JAMA 2013; 310: 482-483
• 17 Najavits LM, Hien D. Helping vulnerable populations: a comprehensive review of the treatment outcome literature on substance use disorder and PTSD. J Clin Psychol 2013; 69: 433-479
• 18 Rounsaville BJ, Kranzler HR, Ball SA. et al. Personality disorders in substance abusers: relation to substance abuse. J Nerv Mental Diseases 1998; 186: 87-95
• 19 Lenzenweger MF, Lane MC, Loranger AW. et al. DSM-IV Personality disorders in the national comorbidity survey replication. Biol Psychiat 2007; 62: 553-564
• 20 Kienast T, Roediger E, Kensche M. et al. Evidenzbasierte Psychotherapie – Sucht und Persönlichkeitsstörung als Komorbidität. Nervenarzt 2009; 80: 1050-1059
• 21 Kienast T, Stoffers J, Bermpohl F. et al. Borderline-Persönlichkeitsstörung und komorbide Abhängigkeitserkrankungen, Epidemiologie, biologische Grundlagen und Therapie. Dtsch Ärztebl 2013; 0
• 22 Longabaugh R, Rubin A, Malloy P. et al. Drinking outcomes of alcohol abusers diagnosed as antisocial personality disorder. Alcohol Clin Exp Res 1994; 18: 778-785
• 23 Mercer C, Woody G. Psychotherapie bei Kokainabhängigkeit. Suchttherapie 2002; 3: 13-17
• 24 Kessler RC, Berglund P, Demler O. et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiat 2006; 62: 593-602
• 25 van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W. et al. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend Drug 2012; 122: 11-19
• 26 Sonuga-Barke EJ, Brandeis D, Cortese S. et al. European ADHD Guidelines Group. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiat 2013; 170: 275-289
• 27 Matthys F, Joostens P, van den Brink W. et al. Summary of the practice guideline for the diagnosis and treatment of ADHD in adolescents and adults with addictions. Ned Tijdschr Geneeskd 2013; 157: 6025
• 28 Klassen LJ, Bilkey TS, Katzman MA. et al. Comorbid attention deficit/hyperactivity disorder and substance use disorder: treatment considerations. Curr Drug Abuse Rev 2012; 5: 190-198
• 29 Schneider B. Substance use disorders and risk for completed suicide. Arch Suicide Res 2009; 13: 303-316
• 30 Esposito-Smythers C, Spirito A, Kahler CW. Treatment of co-occurring substance abuse and suicidality among adolescents: a randomized trial. J Consult Clin Psychol 2011; 79: 728-739